Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
High-Dose Etoposide Treatment for CNS Involvement in a Patient with Primary Non-Hodgkin's Lymphoma of the Breast
Hiroyuki KOHARAHiroshi UEOKAMasahiro TABATAKatsuji SHINAGAWAKyoichi HAYASHIMine HARADA
Author information
JOURNAL FREE ACCESS

1997 Volume 36 Issue 10 Pages 738-741

Details
Abstract

A 46-year-old man was referred to us for treatment of non-Hodgkin's lymphoma (NHL; diffuse large immunoblastic B cell type), which had initially developed in the breast. He was treated with five courses of chemotherapy with CHOP (cyclophosphamide, adriamycin, vincristine, and prednisolone) and achieved a complete response. One year later, he noticed a gait disturbance. Magnetic resonance imaging (MRI) of the brain showed multiple nodules. A few abnormal cells were found in the cerebrospinal fluid (CSF). He was treated with high-dose etoposide (1, 350 mg/m2/course). After two courses, both the multiple nodular lesions in the brain and the abnormal cells in the CSF were resolved. High-dose etoposide is effective for CNS involvement by NHL.
(Internal Medicine 36: 738-741, 1997)

Content from these authors
© The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top